Increased plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in lung and breast cancer are altered during chest radiotherapy
H. Susskind(Brookhaven National Laboratory), Stanley Zucker(Northport VA Medical Center), Adam Hurewitz(State University of New York), Michelle Hymowitz(Northport VA Medical Center), Edward S. Valentine(State University of New York), Y.H. Lau(State University of New York), Allen G. Meek(State University of New York), Harold Atkins(University of Ottawa)
International Journal of Radiation Oncology*Biology*Physics
June 30, 2003
Cited by 38
Related Papers
VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents
|Cancer Cell|2003|850
Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus
|Nature Medicine|2000|816
A FLUORINATED GLUCOSE ANALOG, 2-FLUORO-2-DEOXY-D-GLUCOSE (F-18)
|Journal of Computer Assisted Tomography|1980|503
Glucose Metabolic Rate Kinetic Model Parameter Determination in Humans: The Lumped Constants and Rate Constants for [ <sup>18</sup> F]Fluorodeoxyglucose and [ <sup>11</sup> C]Deoxyglucose
|Journal of Cerebral Blood Flow & Metabolism|1985|419